XNK Therapeutics completes building phase of new GMP facility
XNK Therapeutics AB (“XNK”) today announced the successful completion of the building phase of the company’s new GMP clean room facility.All equipment and systems are now installed, and qualification of the clean room is complete, while validation and qualification of equipment and systems are progressing according to plan. The first technical batch has been produced in the facility, demonstrating the ability to run a production process. “XNK has worked hard over the past year planning for this new GMP facility that will enable the aseptic production of ATMPs and clinical material for